3.62
-0.05 (-1.36%)
| Penutupan Terdahulu | 3.67 |
| Buka | 3.61 |
| Jumlah Dagangan | 89,755 |
| Purata Dagangan (3B) | 237,579 |
| Modal Pasaran | 86,696,104 |
| Harga / Jualan (P/S) | 1.14 |
| Harga / Buku (P/B) | 9.89 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 18 Aug 2025 |
| Margin Keuntungan | -106.77% |
| Margin Operasi (TTM) | -52.24% |
| EPS Cair (TTM) | -2.64 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 49.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -60.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 778.95% |
| Nisbah Semasa (MRQ) | 0.380 |
| Aliran Tunai Operasi (OCF TTM) | -6.40 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 10.32 M |
| Pulangan Atas Aset (ROA TTM) | -17.42% |
| Pulangan Atas Ekuiti (ROE TTM) | -232.51% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menurun |
| Biotechnology (Global) | Bercampur | Menurun | |
| Stok | Celularity Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | -0.5 |
| Purata | -1.75 |
|
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 51.26% |
| % Dimiliki oleh Institusi | 14.66% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| C V Starr & Co Inc | 30 Jun 2025 | 764,069 |
| Valmark Advisers, Inc. | 30 Jun 2025 | 49,983 |
| Keynote Financial Services Llc | 30 Jun 2025 | 23,480 |
| Julat 52 Minggu | ||
| Median | 6.00 (65.75%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| WBB Securities | 09 Sep 2025 | 6.00 (65.75%) | Beli | 2.26 |
| 18 Aug 2025 | 6.00 (65.75%) | Tidak Dinilai | 4.15 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 03 Sep 2025 | Pengumuman | Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance |
| 22 Aug 2025 | Pengumuman | Celularity Receives Nasdaq Notice Regarding Form 10-Q |
| 18 Aug 2025 | Pengumuman | Celularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured Debt |
| 09 Jul 2025 | Pengumuman | Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law |
| 01 Jul 2025 | Pengumuman | Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |